Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 150358, 9 pages
http://dx.doi.org/10.1155/2014/150358
Research Article

Association of Polymorphisms of Genes Involved in Lipid Metabolism with Blood Pressure and Lipid Values in Mexican Hypertensive Individuals

1División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada No. 800, Colonia Independencia, 44340 Guadalajara, JAL, Mexico
2Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44348 Guadalajara, JAL, Mexico
3Instituto de Genética Humana “Enrique Corona Rivera”, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44348 Guadalajara, JAL, Mexico
4Unidad de Investigación Epidemiológica y en Servicios de Salud del Adolescente, Instituto Mexicano del Seguro Social, Avenida Tonalá 121, 45400 Tonalá, JAL, Mexico
5División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada No. 800, Colonia Independencia, 44340 Guadalajara, JAL, Mexico

Received 18 September 2014; Revised 12 November 2014; Accepted 13 November 2014; Published 21 December 2014

Academic Editor: Claudio Letizia

Copyright © 2014 Blanca Estela Ríos-González et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Munguía-Miranda, R. G. Sánchez-Barrera, D. Hernández-Saavedra, and M. C. Cruz-López, “Prevalencia de dislipidemias en una población de sujetos en apariencia sanos y su relación con la resistencia a la insulina,” Salud Pública de México, vol. 50, no. 5, pp. 375–382, 2008. View at Publisher · View at Google Scholar
  2. J. Ran, H. Li, J. Fu et al., “Construction and analysis of the protein-protein interaction network related to essential hypertension,” BMC Systems Biology, vol. 7, article 32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Skrapari, N. Tentolouris, and N. Katsilambros, “Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome,” Current Diabetes Reviews, vol. 2, no. 3, pp. 329–338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Gadegbeku, A. Dhandayuthapani, Z. E. Sadler, and B. M. Egan, “Raising lipids acutely reduces baroreflex sensitivity,” American Journal of Hypertension, vol. 15, no. 6, pp. 479–485, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. T. Stepniakowski, T. L. Goodfriend, and B. M. Egan, “Fatty acids enhance vascular α-adrenergic sensitivity,” Hypertension, vol. 25, no. 4, pp. 774–778, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Villela, L. G. Kramer-Aguiar, D. A. Bottino, N. Wiernsperger, and E. Bouskela, “Metabolic disturbances linked to obesity: the role of impaired tissue perfusion,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 2, pp. 238–245, 2009. View at Google Scholar · View at Scopus
  7. P. J. Talmud, J. Palmen, W. Putt, L. Lins, and S. E. Humphries, “Determination of the functionality of common APOA5 polymorphisms,” Journal of Biological Chemistry, vol. 280, no. 31, pp. 28215–28220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Mattei, S. Demissie, K. L. Tucker, and J. M. Ordovas, “Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults,” Journal of Nutrition, vol. 139, no. 12, pp. 2301–2308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Martin, V. Nicaud, S. E. Humphries, and P. J. Talmud, “Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1637, no. 3, pp. 217–225, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Benn, B. G. Nordestgaard, J. S. Jensen, and A. Tybjærg-Hansen, “Polymorphisms in apolipoprotein B and Risk of ischemic stroke,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3611–3617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Auinger, U. Helwig, D. Rubin et al., “Human intestinal fatty acid binding protein 2 expression is associated with fat intake and polymorphisms,” The Journal of Nutrition, vol. 140, no. 8, pp. 1411–1417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A.-P. Liu, S.-Y. Zhan, L.-M. Li et al., “Association between AvaII exon 13 polymorphism at the LDL receptor gene different and serum lipid levels in normotensives and essential hypertensives in Shanghai,” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 24, no. 7, pp. 542–546, 2003. View at Google Scholar · View at Scopus
  13. X. J. Long, R. X. Yin, K. L. Li et al., “Low density lipoprotein receptor gene Ava II polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations,” Lipids in Health and Disease, vol. 10, article 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Isaacs, F. A. Sayed-Tabatabaei, O. T. Njajou, J. C. Witteman, and C. M. Van Duijn, “The −514 CT hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3858–3863, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Rip, M. C. Nierman, C. J. Ross et al., “Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. 1236–1245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Ledmyr, A. D. McMahon, E. Ehrenborg et al., “The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease,” Circulation, vol. 109, no. 19, pp. 2279–2284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Norma Oficial Mexicana, “Para la prevención, detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica,” NOM-030-SSA2-2009, 2009. View at Google Scholar
  18. B. E. Ríos-González, K. E. Luévano-Ortega, A. M. Saldaña-Cruz, J. R. González-García, and M. T. Magaña-Torres, “Polymorphisms of seven genes involved in lipid metabolism in an unselected Mexican population,” Journal of Genetics, vol. 90, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Norma Oficial Mexicana, “Para la prevención, tratamiento y control de las dislipidemias,” NOM-037-SSA2-2002, 2002. View at Google Scholar
  20. K. E. Luévano, J. R. González, F. J. Perea, and M. T. Magaña, “Linkage disequilibrium between four MTTP gene polymorphisms in a Mexican population,” Annals of Human Biology, vol. 36, no. 2, pp. 211–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Hong, J. Song, and J. Q. Kim, “The haplotype analyses using multiple markers of the apolipoprotein B gene in patients with coronary artery disease,” Journal of Korean Medical Science, vol. 16, no. 6, pp. 719–724, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Scartezini, M. A. Zago, E. A. Chautard-Freire-Maia et al., “The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample,” Brazilian Journal of Medical and Biological Research, vol. 36, no. 3, pp. 369–375, 2003. View at Google Scholar · View at Scopus
  23. B. Li, D. Ge, Y. Wang et al., “Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population,” Hypertension Research, vol. 27, no. 6, pp. 373–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Aguilar-Salinas, F. J. Gómez-Pérez, J. Rull, S. Villalpando, S. Barquera, and R. Rojas, “Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006,” Salud Publica de Mexico, vol. 52, no. 1, pp. S44–S53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Barquera, I. Campos-Nonato, L. Hernández-Barrera et al., “Hypertension in mexican adults: results from the National Health and Nutrition Survey 2006,” Salud Pública de México, vol. 52, supplement 1, pp. S63–S71, 2010. View at Google Scholar · View at Scopus
  26. P. Conthe, P. Gómez-Fernández, F. de Álvaro, C. Fernández-Pérez, J. González-Esteban, and L. Cea-Calvo, “HDL cholesterol and cardiovascular disease in a population with hypertension and type 2 diabetes mellitus. RICARHD study,” Revista Clinica Española, vol. 209, no. 5, pp. 227–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-J. Ariza, M.-Á. Sánchez-Chaparro, F.-J. Barón et al., “Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: Results of the ICARIA genetic sub-study,” BMC Medical Genetics, vol. 11, article 66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Guardiola, J. Ribalta, D. Gómez-Coronado, M. A. Lasunción, M. de Oya, and C. Garcés, “The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (four provinces study),” Atherosclerosis, vol. 212, no. 2, pp. 543–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. B. D. Chiodini, S. Barlera, M. G. Franzosi, V. L. Beceiro, M. Introna, and G. Tognoni, “APO B gene polymorphisms and coronary artery disease: a meta-analysis,” Atherosclerosis, vol. 167, no. 2, pp. 355–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. A. de Luis, R. Aller, O. Izaola, M. Gonzalez Sagrado, and R. Conde, “Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects,” Annals of Nutrition and Metabolism, vol. 50, no. 4, pp. 354–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Liu, C. Zhai, P. Cao, Y. Zheng, S. Zhou, and J. Chi, “FABP2 gene polymorphism and metabolic disorder of lipids in the middle aged and aged population,” Wei Sheng Yan Jiu, vol. 40, no. 4, pp. 461–464, 2011. View at Google Scholar · View at Scopus
  32. X. S. Wang, H. Bai, P. Fan, R. Liu, Y. Liu, and B. W. Liu, “Analysis of the FABP2 gene Ala54Thr polymorphism in non-obese and obese Chinese,” Sichuan Da Xue Xue Bao. Yi Xue Ban, vol. 42, no. 1, pp. 19–23, 2011. View at Google Scholar
  33. C. Wang, T. Sun, H. Li, J. Bai, and Y. Li, “Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: a meta-analysis,” Thrombosis Research, vol. 128, no. 5, pp. e107–e112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Q. Niu and Y. Qi, “Meta-based association of the lipoprotein lipase gene S447X variant with hypertension and blood pressure variation,” Journal of Human Hypertension, vol. 25, no. 6, pp. 383–390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Lundahl, T. P. Leren, L. Ose, A. Hamsten, and F. Karpe, “A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 7, pp. 1784–1788, 2000. View at Publisher · View at Google Scholar · View at Scopus